CIMA LABS INC
10-C, 1996-05-21
PHARMACEUTICAL PREPARATIONS
Previous: DRUG EMPORIUM INC, DEF 14A, 1996-05-21
Next: TOYOTA MOTOR CREDIT CORP, 424B3, 1996-05-21



<PAGE>

Form 10-C


Securities and Exchange Commission
Washington, DC 20549

Report by issuer of securities quoted on The Nasdaq Stock Market-Signature 
Mark-, filed pursuant to Section 13 or 15(d) of the Securities Exchange Act 
of 1934 and Rule 13a-17 or 15d-17 thereunder.

EXACT NAME OF ISSUER 
 AS SPECIFIED IN CHARTER:  CIMA LABS, INC.
                         --------------------------------------------

ADDRESS OF PRINCIPAL 
 EXECUTIVE OFFICES:   10000 Valley View Road, Eden Prairie, MN 55344
                    -------------------------------------------------

ISSUER'S TELEPHONE NUMBER 
 (INCLUDING AREA CODE):   (612) 947-8700
                        ---------------------------------------------


I. Change in Number of Shares Outstanding

Indicate any change (increase or decrease) of five percent or more in the 
number of shares outstanding:

1. Title of security   Common Stock, $.01 par value
                     ----------------------------------------------------
2. Number of shares 
   outstanding before 
   the change     7,859,214
                ---------------------------------------------------------
3. Number of shares 
   outstanding after 
   the change     9,328,793
                ----------------------------------------------------------
4. Effective date 
   of change      April 15, 1996
                ----------------------------------------------------
5. Method of change 

Specify method (such as merger, acquisition, exchange, distribution, 
stock split, reverse split, acquisition of stock for treasury, etc.)
           Public Offering
- -------------------------------------------------------------------------

Give brief description of transaction

     Public Offering pursuant to Registration Statement on Form S-1
     --------------------------------------------------------------------

II. Change in Name of Issuer

1. Name prior to change     
                         ------------------------------------------------
2. Name after change    
                      ---------------------------------------------------
3. Effective date 
   of charter amendment 
   changing name     
                  -------------------------------------------------------
4. Date of shareholder 
   approval of change, 
   if required     
                ---------------------------------------------------------


                                        President, Chief Executive Officer 
 May 20, 1996     /s/  JOHN M. SIEBERT   and Chief Financial Officer
- --------------   --------------------------------------------------------
     DATE                 OFFICER'S SIGNATURE AND TITLE      



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission